Roche Receives Approval For Laboratory Based Elecsys SARS-CoV-2 Antigen Test To Facilitate High-Volume Testing In Country
Roche announced today that it has launched a high-throughput SARS-CoV-2 antigen test as an aid in the diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections. The laboratory-based Elecsys…
Share